|
EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year
21-Aug-2025 / 17:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months.
For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million).
License sales are below expectations and cannot be offset by maintenance revenues and other revenues.
************************************************************************
Contact:
Kirchhoff, Marcus / CEO
End of Inside Information
21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MeVis Medical Solutions AG |
|
Caroline-Herschel-Str. 1 |
|
28359 Bremen |
|
Germany |
| Phone: |
+49 421 224 95 0 |
| Fax: |
+49 421 224 95 999 |
| E-mail: |
ir@mevis.de |
| Internet: |
http://www.mevis.de |
| ISIN: |
DE000A0LBFE4 |
| WKN: |
A0LBFE |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
2187294 |
| |
| End of Announcement |
EQS News Service |
2187294 21-Aug-2025 CET/CEST
EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Forecast adjustment for the 2024/2025 fiscal year
21-Aug-2025 / 17:45 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Bremen, August 21, 2025 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its forecast for the current fiscal year based on preliminary figures for the first ten months.
For fiscal year 2024/2025 (October 1, 2024 to September 30, 2025), revenue is now expected to decline slightly to between €16.5 million and €17.0 million (previous forecast: €17.0 million to €17.5 million). MeVis expects EBIT (earnings before interest and taxes) to decline to between €3.0 million and €3.5 million (previous forecast: €3.5 million to €4.0 million).
License sales are below expectations and cannot be offset by maintenance revenues and other revenues.
************************************************************************
Contact:
Kirchhoff, Marcus / CEO
End of Inside Information
21-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 |
| 28359 Bremen |
| Germany |
| Phone: |
+49 421 224 95 0 |
| Fax: |
+49 421 224 95 999 |
| E-mail: |
ir@mevis.de |
| Internet: |
http://www.mevis.de |
| ISIN: |
DE000A0LBFE4 |
| WKN: |
A0LBFE |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
2187294 |
| |
| End of Announcement |
EQS News Service |
2187294 21-Aug-2025 CET/CEST
![\"\"](\"https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2187294&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6\")
|